MedPath

Self-adherent Absorbent Silver Dressing in Adults After Hip or Knee Arthroplasty

Not Applicable
Completed
Conditions
Arthroplasties, Hip Replacement
Arthroplasties, Knee Replacement
Interventions
Device: Mepilex Border Post-Op Ag
Registration Number
NCT03016078
Lead Sponsor
Molnlycke Health Care AB
Brief Summary

The overall rationale for this investigation is to evaluate the clinical performance potential for Mepilex Border Post-Op Ag in the ability to minimize the risk of skin related post-operative wound complications such as blistering, maceration and redness at the incision and surrounding skin.

Detailed Description

This was a descriptive, open, prospective, non-controlled clinical investigation conducted on 21 enrolled subjects at one site in the United states of America (USA).

The target subjects were male or female, 18 years and older, undergoing elective primary hip or knee arthroplasty with a possibility to participate in a follow-up visit 7 days after surgery. The primary purpose was to investigate if there was any skin damage under the dressing from operation day to last visit. Performance of the dressing as well as comfort, conformability, acceptability and pain at dressing removal was also followed-up until post-op day 7.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  1. Age ≥ 18 years
  2. Available for a follow-up visit including dressing change 7 days after surgery
  3. Plan for elective primary hip or knee arthroplasty
  4. Plan for incision size ≤18 cm
  5. Provision of informed consent i.e. subject must be able to understand and sign the Patient Information and Consent Form
  6. Undergoing elective primary arthroplasty of the hip or knee.

Exclusion Criteria

  1. Known allergy/hypersensitivity to any of the components of the dressing
  2. Multi-trauma
  3. Undergoing arthroplasty due to tumor
  4. Previous incision at the same knee or same side of the hip
  5. Wound at the surgical site prior to surgery
  6. Neurological deficit of operated side (hemiplegia, etc.)
  7. Documented skin disease at time of enrollment, as judged by the investigator
  8. Previously enrolled in the present investigation
  9. Inclusion in other ongoing investigations at present that would preclude the subject from participating in this investigation as judged by the investigator
  10. Involvement in the planning and conduct of the clinical investigation (applies to all MHC staff, investigational site staff and third party vendor)
  11. Dressing size does not fit the incision area (>18 cm)
  12. Complications that would increase wound risks if investigational dressing is applied
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mepilex Border Post-Op Ag DressingMepilex Border Post-Op AgA soft silicone foam dressing that absorbs wound exudate maintains a moist wound healing environment and has antimicrobial properties
Primary Outcome Measures
NameTimeMethod
Number of Participants With Damage to the Incision and Surrounding SkinDaily visits, up to 7 days

The primary outcome is damage to the incision and surrounding skin from operation day to last visit in terms of:

* Blistering (Yes/No) by visit

* Redness under dressing (Yes/No) by visit

* Redness outside dressing (Yes/No) by visit

* Maceration under dressing (Yes/No) by visit

* Maceration outside dressing (Yes/No) by visit

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Dressing Sticking to the Staples/SuturesDaily visits, up to 7 days

Nurse/ Investigator evaluate: Dressing sticks to the staples/sutures (No/Yes)

Evaluation of the Dressing Capacity of Handling BloodDaily visits, up to 7 days

Nurse or Investigator evaluate: Poor, Good, Very Good,Very Good, Excellent on a Likert scale.

Participants' Dressing Wear Time (Days)7 days

The number of days the dressing can stay on are evaluated

Number of Participants With Bleeding Caused by Dressing RemovalDaily visits, up to 7 days

Nurse/ Investigator evaluate: Bleeding caused by dressing removal (No/Yes)

Number of Dressing Changes Per SubjectDaily visits, up to 7 days

To evaluate the number of dressing changes per subject

Number of Participants With Leakage of the DressingDaily visits, up to 7 days

Nurse/ Investigator evaluate: Leakage (No/Yes)

Residuals of the Dressing Material in the Wound or Surrounding Skin at Any Visit (for Patients With at Least One Dressing Change)Daily visits, up to 7 days

Residuals of the dressing material in the wound or surrounding skin at any visit (for patients with at least one dressing change).

Nurse/ Investigator evaluate with No/Yes

Trial Locations

Locations (1)

The CORE Institute Gilbert

🇺🇸

Gilbert, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath